Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment

cDNA microarray data conducted by our group revealed overexpression of CXCL2 and CXCL8 in ovarian cancer (OC) microenvironment. Herein, we have proven that the chemokine receptor, CXCR2, is a pivotal molecule in re-sensitizing OC to cisplatin, and its inhibition decreases cell proliferation, viabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Henriques, Taciane Barbosa, dos Santos, Diandra Zipinotti, dos Santos Guimarães, Isabella, Tessarollo, Nayara Gusmão, Lyra-Junior, Paulo Cilas Morais, Mesquita, Patricia, Pádua, Diana, Amaral, Ana Luisa, Cavadas, Bruno, Pereira, Luisa, Silva, Ian Victor, Almeida, Raquel Maria da Silva Graça, Rangel, Leticia Batista Azevedo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202899/
https://www.ncbi.nlm.nih.gov/pubmed/34038868
http://dx.doi.org/10.18632/aging.203074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202899/
https://www.ncbi.nlm.nih.gov/pubmed/34038868
http://dx.doi.org/10.18632/aging.203074

Ejemplares similares